Middle East & Africa Overactive Bladder Treatment Market Size & Outlook
Related Markets
MEA overactive bladder treatment market highlights
- The MEA overactive bladder treatment market generated a revenue of USD 108.9 million in 2023.
- The market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, mirabegron was the largest revenue generating type in 2023.
- Neuromodulation is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 108.9 million |
| Market revenue in 2030 | USD 159.9 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Mirabegron |
| Fastest growing segment | Neuromodulation |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticholinergics, Mirabegron, Botox, Neuromodulation, Other |
| Key market players worldwide | Pfizer Inc, AbbVie Inc, Astellas Pharma Inc, Medtronic PLC, Sumitomo Pharma Co Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd, Hisamitsu Pharmaceutical Co Inc, Par Pharmaceutical |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.9% of the global overactive bladder treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,293.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Overactive Bladder Treatment Market Scope
Overactive Bladder Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Par Pharmaceutical | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | https://parsterileproducts.com |
| Sumitomo Pharma Co Ltd | View profile | 6250 | 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Japan, 541-0045 | https://www.sumitomo-pharma.com |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | http://www.hisamitsu.co.jp |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Middle East & Africa overactive bladder treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to overactive bladder treatment market will help companies and investors design strategic landscapes.
Mirabegron was the largest segment with a revenue share of 27.64% in 2023. Horizon Databook has segmented the Middle East & Africa overactive bladder treatment market based on anticholinergics, mirabegron, botox, neuromodulation, other covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa overactive bladder treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa overactive bladder treatment market databook
-
Our clientele includes a mix of overactive bladder treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa overactive bladder treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa overactive bladder treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA overactive bladder treatment market report size, by country, 2018-2030 (US$M)
Middle East & Africa Overactive Bladder Treatment Market Share, 2023 & 2030 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
